Greenlining Institute Supports Lee-Halpern Petition
By Robert Gnaizda
| 02. 16. 2005
Support For Diversity and Compensation Issues Raised in the Lee-Halpern Petition by the Greenlining Institute
Dear Mr. Klein,
On behalf of Greenlining Institute, we would like to offer to you and the Independent Citizens Oversight Committee our views on two issues in which we have expertise and have been highly involved that have been raised in the Lee-Halpern petition.
First, an essential issue before the Institute is diversity. The issue is of great importance, particularly since the Independent Oversight Committee is admittedly not reflective of California's diversity. This has been compounded by the failure to ensure effective diversity on the first nine hires and apparently in the recommendation of the Interim President of the California Institute for Regenerative Medicine.
Greenlining believes that all regulations should be considered in the context of ensuring full diversity. This includes making diversity a crucial element in evaluating all grants, loans, contracts and hires.
Second, Greenlining has been involved in a wide range of excessive executive compensation cases, including a recent one before the California Public Utilities Commission in the PG&E rate case. Greenlining has also criticized excessive compensation at universities, including U.C.
We believe that there is no correlation...
Related Articles
By Jared Whitlock, Endpoints News | 07.15.2025
Patient groups face a harder and unpredictable path going state-by-state to boost screening for rare but treatable conditions after the Trump administration disbanded a federal advisory committee on newborn screening.
In April, the Advisory Committee on Heritable Disorders in Newborns...
By Pat Duggins, Alabama Public Radio | 06.27.2025
PAT DUGGINS-- If I were to say, ‘man, have you seen the price of eggs these days?’ You're probably thinking, Oh, he's talking about inflation and the price of groceries and how it became an issue in the presidential race...
By Ron Leuty, San Francisco Business Times | 06.16.2025
23andMe's two-step sale to a nonprofit led by former CEO Anne Wojcicki is nothing more than a dance around California's genetic privacy law, state Attorney General Rob Bonta said in a filing late Monday, one day before a judge will...
By Staff, The Associated Press | 06.10.2025
PORTLAND, Ore. — Twenty-seven states and the District of Columbia on Monday filed a lawsuit in bankruptcy court seeking to block the sale of personal genetic data by 23andMe without customer consent. The lawsuit comes as a biotechnology company seeks...